These data suggest that oridonin exhibits a selective inhibitory effect on DNMT3A R882 mutant cells, and the OCI-AML3 cell line is a good model to study leukemia with DNMT3A R882 mutation as described by several studies [5, 10, 14]. This evidence concerns the gene DNMT3A and leukemia.